Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE Trial)

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1664-1671

  Sidhu, Sandeep Singh ^a   Goyal, Omesh ^a   Singla, Preeti ^a   Gupta, Dinesh ^a   Sood, Ajit ^a   Chhina, Rajoo Singh ^a   Soni, Ravinder Kumar ^a  

^a DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Corticosteroids; Lille score; Pentoxifylline; Severe alcoholic hepatitis

Indexed keywords

CORTICOSTEROID; PENTOXIFYLLINE; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HAZARD RATIO; HEADACHE; HUMAN; INFECTION; LILLE SCORE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PANCREATITIS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SURVIVAL RATE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; VOMITING;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANALYSIS OF VARIANCE; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEPATITIS, ALCOHOLIC; HOSPITALIZATION; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PENTOXIFYLLINE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864219469     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2097-4     Document Type: Article

References (34)

1. Mathurin P. Corticosteroids for alcoholic hepatitis - what's next? J Hepatol. 2005;43:526-533. (Pubitemid 41111436)
2. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758-2769.
3. Taieb J, Mathurin P, Elbim C, et al. Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids. J Hepatol. 2000;32:579-586. (Pubitemid 30180377)
4. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med. 1990;172:391-394. (Pubitemid 20217287)
5. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis: a meta analysis adjusting for confounding variables. Ann Intern Med. 1990;113:299-307. (Pubitemid 20254358)
6. Daures JP, Peray P, Bories P, et al. Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis. Gastroenterol Clin Biol. 1991;15:223-228.
7. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol. 2002;36:480-487. (Pubitemid 34407335)
8. Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60: 255-260.
9. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta analysis adjusting for confounding variables. Gut. 1995;37:113-118.
10. Rambaldi A, Saconato HH, Christensen E, et al. Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167-1178. (Pubitemid 351697274)
11. Imperiale TF, O'Connor J, McCullough AJ. Corticosteroids are effective in patients with severe alcoholic patients. Am J Gastroenterol. 1999;94:3066-3067.
12. Christensen E. Alcoholic hepatitis - glucocorticosteroids or not? J Hepatol. 2002;36:547-548.
13. Mathurin P. The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol. 2010;53:392-393.
14. Christensen E. Glucocorticosteroids in acute alcoholic hepatitis: the evidence of a beneficial effect is getting even weaker. J Hepatol. 2010;53:390-391.
15. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol. 1998;93:2022-2036. (Pubitemid 29076847)
16. O'Shea RS, McCullough AJ. Treatment of alcoholic hepatitis. Clin Liver Dis. 2005;9:103-134. (Pubitemid 40341949)
17. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol. 2010;105:14-32.
18. Sass DA, Shaikh OS. Alcoholic hepatitis. Clin Liver Dis. 2006;10:219-237. (Pubitemid 46110782)
19. Doherty GM, Jensen JC, Alexander HR, et al. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery. 1991;110:192-198.
20. Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves shortterm survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637-1648. (Pubitemid 32198689)
21. Sidhu SS, Goyal O, Singla M, et al. Pentoxifylline in severe alcoholic hepatitis: a prospective randomized trial. Trop Gastroenterol. 2009;30:S21-S22.
22. De BK, Gangopadhyay S, Dutta D, et al. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol. 2009;15:1613-1619.
23. Louvet A, Diaz E, Dharancy S, et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol. 2008;48:465-470.
24. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164-176. (Pubitemid 26012105)
25. Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365: 1790-1800.
26. Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348-1354. (Pubitemid 46918318)
27. Mathurin P, Abdelnour M, Ramond MJ, et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy proven alcoholic hepatitis (AH) treated by prednisolone. Hepatology. 2003;38:1363-1369. (Pubitemid 37466961)
28. Mathurin P, Louvet A, Dao T, et al. Addition of pentoxifylline to prednisolone for severe alcoholic hepatitis does not improve 6-month survival: results of the Corpentox trial. Hepatology. 2011;54:81A.
29. Mendenhall C, Roselle GA, Gartside P, et al. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans administration cooperative studies. Alcohol Clin Exp Res. 1995;19:635-641.
30. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41:353-358. (Pubitemid 40165379)
31. Dureja P, Lucey MR. The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol. 2010;52: 759-764.
32. Singal AK, Bashar H, Anand BS, et al. Graft and patient survival after liver transplantation for alcoholic hepatitis - comparison to alcoholic cirrhosis: exploratory analysis based on UNOS data. Hepatology. 2011;54:162A.
33. Nguyen-Khac E, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365:1781-1789.
34. Brown RS Jr. Transplantation for alcoholic hepatitis - time to rethink the 6-month "rule." N Engl J Med. 2011;365:1836-1838.